This section of the Zynex Medical InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. 

Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  Zynex Medical assumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQZYXI
Beta0.66
Shares Outstanding36.6M
Average Volume (10 days)323.5K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)$0.44
Sales (TTM)$3.81
Book Value (MRQ)$1.81
Cash Flow (TTM)$0.35
Cash (MRQ)$0.54

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy3
 
Buy0
 
Hold0
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Daniel J. Moorhead
Chief Financial Officer
(1,986)
Dispose
Mar 6, 2023
Daniel J. Moorhead
Chief Financial Officer
5,000
Acquire
Mar 5, 2023
Daniel J. Moorhead
Chief Financial Officer
(191)
Dispose
Feb 27, 2023
Anna Lucsok
Chief Operating Officer
(245)
Dispose
Feb 6, 2023
Thomas Sandgaard
Director, President, CEO and Chairman, Ten Percent Owner
(611)
Dispose
Feb 6, 2023

Recent SEC Filings

Insider Buy/Sell
Mar 17, 2023
Insider Buy/Sell
Mar 17, 2023
Insider Buy/Sell
Mar 17, 2023
10-K
Mar 14, 2023
Company Events
Mar 13, 2023